JCVI: Under-30s to be offered alternative to AZ vaccine

Video Credit: ODN
Published on April 7, 2021 - Duration: 01:34s

JCVI: Under-30s to be offered alternative to AZ vaccine

The Joint Committee on Vaccination and Immunisation (JCVI) has issued new advice on the use of the Oxford-AstraZeneca vaccine, due to concerns over a very rare risk of blood clots.

Report by Jonesia.

Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn


You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions

AstraZeneca

British pharmaceutical company
In India, almost 90% of people who received Covid vaccine, received the AstraZeneca vaccine which in India is called Covishield.
Credit: DNA - Published 18 hours ago

A dad who suffered a brain injury just days after receiving a British-developed COVID vaccine has told Sky News he would never have had the jab if he had known..
Credit: Sky News - Published 2 days ago


You might like